Botiacrine

Botiacrine
Clinical data
Other names	Mo 876; DMA
Identifiers
	IUPAC name S-[2-(dimethylamino)ethyl] 9,9-dimethylacridine-10-carbothioate;
CAS Number	4774-53-2;
PubChem CID	71202;
ChemSpider	64338;
UNII	032WJR708Q;
ChEMBL	ChEMBL2106109;
CompTox Dashboard (EPA)	DTXSID60963925 ;
Chemical and physical data
Formula	C20H24N2OS
Molar mass	340.49 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1(C2=CC=CC=C2N(C3=CC=CC=C31)C(=O)SCCN(C)C)C;
	InChI InChI=1S/C20H24N2OS/c1-20(2)15-9-5-7-11-17(15)22(18-12-8-6-10-16(18)20)19(23)24-14-13-21(3)4/h5-12H,13-14H2,1-4H3; Key:QXRUCDDVUMKOPI-UHFFFAOYSA-N;

Botiacrine (INNTooltip International Nonproprietary Name; developmental code name Mo 876) is a drug of the tricyclic family described as an antiparkinsonian agent which was either never marketed or was possibly marketed outside of the United States.^[1]^[2]^[3]^[4]^[5] It was first described in the literature by 1965.^[1] The drug is an acridine derivative and is structurally related to the tricyclic antidepressant dimetacrine.^[1]

Other namesMo 876; DMA

Quick facts Clinical data, Other names ...

Close

References